Endogenous fibrinolysis facilitates clot retraction in vivo
Open Access
- 7 December 2017
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 130 (23) , 2453-2462
Abstract
Key Points: Localized vascular injury with thrombin microinjection produces a fibrin network that undergoes myosin IIa–dependent retraction in vivo. Using this model, we demonstrate that endogenous fibrinolysis promotes fibrin clot retraction.Keywords
This publication has 26 references indexed in Scilit:
- Recombinant tissue plasminogen activators (rtPA): A reviewClinical Pharmacology & Therapeutics, 2015
- Mechanics and contraction dynamics of single platelets and implications for clot stiffeningNature Materials, 2010
- Dynamic Tyrosine Kinase-Regulated Signaling and Actin Polymerisation Mediate Aggregate Stability Under ShearArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growthBlood, 2008
- Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretionBlood, 2007
- MyosinIIa contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stabilityJournal of Thrombosis and Haemostasis, 2007
- Nonmuscle Myosin Heavy Chain IIA Mutations Define a Spectrum of Autosomal Dominant Macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein, and Alport-Like SyndromesThe American Journal of Human Genetics, 2001
- A Millennial Myosin CensusMolecular Biology of the Cell, 2001
- Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromesNature Genetics, 2000
- THE SYNERESIS OF BLOOD CLOTSQuarterly Journal of Experimental Physiology (1908), 1923